These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39028612)

  • 1. Screening and anti-angiogenesis activity of Chiloscyllium plagiosum anti-human VEGFR2 single-domain antibody.
    Guo Y; Wang R; Wang Y; Zheng F; Chen J; Lyu Z; Yuan C; Liu L; Jiang X
    Clin Exp Immunol; 2024 Oct; 218(2):177-187. PubMed ID: 39028612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
    Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
    Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
    Jiang X; Sun S; Li Z; Chen M
    Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
    Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
    Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of a human nanobody against VEGFR-2.
    Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE
    Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
    Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
    Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
    Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
    MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bamboo Shark as a Small Animal Model for Single Domain Antibody Production.
    Wei L; Wang M; Xiang H; Jiang Y; Gong J; Su D; Al Azad MAR; Dong H; Feng L; Wu J; Chan LL; Yang N; Shi J
    Front Bioeng Biotechnol; 2021; 9():792111. PubMed ID: 34957081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum).
    Li W; Chen M; Wang T; Feng X; Jiang X; Dong X; Zhang H; Tang X; Tian R; Zhang Y; Li Z
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):133082. PubMed ID: 38878923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF
    Camacho-Villegas TA; Mata-González MT; García-Ubbelohd W; Núñez-García L; Elosua C; Paniagua-Solis JF; Licea-Navarro AF
    Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein.
    Chen YL; Lin JJ; Ma H; Zhong N; Xie XX; Yang Y; Zheng P; Zhang LJ; Jin T; Cao MJ
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
    Dooley H
    Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF.
    Ghasemali S; Barzegar A; Farajnia S; Rahmati M; Negahdari B; Etemadi A; Nazari A
    Anticancer Agents Med Chem; 2023; 23(14):1678-1688. PubMed ID: 37194933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets.
    Yin X; Lin X; Ren X; Yu B; Liu L; Ye Z; Chen Q; Lee C; Lu W; Yu D; Li X
    Pharmacol Res; 2019 Aug; 146():104277. PubMed ID: 31112749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
    Yang J; Wang Q; Qiao C; Lin Z; Li X; Huang Y; Zhou T; Li Y; Shen B; Lv M; Feng J
    Cell Mol Immunol; 2014 May; 11(3):285-93. PubMed ID: 24608894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
    Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shark anti-idiotypic variable new antigen receptor specific for an alpaca nanobody: Exploration of a nontoxic substitute to ochratoxin A in immunoassay.
    Xie X; He Z; Sun Z; Zhang S; Cao H; Hammock BD; Liu X
    J Hazard Mater; 2024 Sep; 477():135264. PubMed ID: 39032175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis.
    Fang X; Xie H; Luo M; Chen Z; Wang F; Li Q; Wang X; Ding J; Fu L
    Biochem Pharmacol; 2018 Apr; 150():131-140. PubMed ID: 29408327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.